Physician

Gilbert J Zoghbi

According to 2025 Medicare claims, Gilbert Zoghbi (NPI: 1306856851) practices interventional cardiology in the Memphis, TN-MS-AR market, with the plurality of this provider's patient population coming from De Soto, MS. This provider's primary affiliated billing organization is STERN CARDIOVASCULAR FOUNDATION, INC (NPI: 1316242266; TIN: 274396698) and primary practice location at 38671-9998. Zoghbi is affiliated with the Baptist Connected Care Solutions, Inc. (ACO ID: A5693), participating under the MSSP model.

Zoghbi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,373 traditional Medicare patients, billed 4,689 HCPCS/CPT codes, and received $280,334 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 8,073 prescription claims across 811 beneficiaries totaling $1,166,785 in drug costs, led by Eliquis (Apixaban). 2023 DME data shows 114 claims. Open Payments data shows 30 records totaling $1,171. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $209,587 to $1,166,785. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $19,435 to $3,105.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,216	5,721	$357,032
2016	1,256	5,440	$347,702
2017	1,374	5,626	$372,250
2018	1,509	6,302	$372,126
2019	1,598	6,698	$423,256
2020	1,359	5,840	$353,810
2021	1,617	6,108	$394,651
2022	1,480	5,448	$329,489
2023	1,334	4,641	$298,750
2024	1,373	4,689	$280,334

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	443	6,525	$209,587
2016	522	8,664	$315,092
2017	580	9,866	$475,265
2018	590	9,296	$494,633
2019	592	8,058	$564,991
2020	614	7,499	$527,610
2021	672	7,599	$602,728
2022	737	7,614	$728,093
2023	785	7,760	$1,019,304
2024	811	8,073	$1,166,785

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	41	$1,504
2016	N/R	48	$38,860
2017	N/R	23	$4,082
2018	N/R	N/R	N/R
2019	N/R	79	$4,981
2020	N/R	206	$14,487
2021	N/R	156	$9,366
2022	N/R	112	$6,892
2023	N/R	114	$8,296
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	346	484	$78
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	643	654	$58
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	214	238	$55
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	197	208	$9
36415	Insertion of needle into vein for collection of blood sample	237	306	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	365	17,250	$333,430
Entresto	Sacubitril/Valsartan	236	11,675	$255,838
Jardiance	Empagliflozin	117	7,063	$137,716
Farxiga	Dapagliflozin Propanediol	108	5,373	$101,737
Xarelto	Rivaroxaban	84	4,623	$85,656

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	30	$1,171	Edwards Lifesciences Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Gilbert J. Zoghbi?

Tedicare shows public-source Medicare data for Gilbert J. Zoghbi (NPI 1306856851), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gilbert J. Zoghbi have ACO affiliation data?

Gilbert J. Zoghbi is shown with ACO affiliation data for Baptist Connected Care Solutions, Inc. (MSSP, ACO ID A5693).

What billing organization is linked to Gilbert J. Zoghbi?

Gilbert J. Zoghbi is linked to STERN CARDIOVASCULAR FOUNDATION, INC (billing NPI 1316242266) in the available physician profile data.

Does Gilbert J. Zoghbi have Open Payments data?

Gilbert J. Zoghbi has 30 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.